Cholesterol reduction in patients with lower limb atherosclerotic disease

Jean Bismuth, Steen Christian Kofoed, Henrik H. Sillesen

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Patients with peripheral arterial disease (PAD) have a 2-3 times increased risk of death and in the most severe stage, critical peripheral ischaemia, the mortality rate is around 50% within 4-5. This poor survival rate is due to concomitant coronary and cerebrovascular atherosclerotic disease. Among the major risk factors for atherosclerosis are dyslipidaemia, smoking, hypertension and diabetes. Large randomised trials have shown that dyslipidaemia is easily modifiable in both patients with and without established coronary artery disease, with significant reductions in cardiovascular morbidity and mortality. Although none of these trials directly measured peripheral vascular status, there is ever indication that conclusions submitted for patients with ischaemic heart disease can be translated to patients with peripheral vascular disease. The object of this review was therefore to divulge current evidence available supporting active treatment of dyslipidaemia in patients with peripheral vascular disease.

Original languageEnglish (US)
Pages (from-to)61-64
Number of pages4
JournalDanish Medical Bulletin
Issue number1
StatePublished - Feb 27 2002

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Cholesterol reduction in patients with lower limb atherosclerotic disease'. Together they form a unique fingerprint.

Cite this